Zdrowie i gospodarka · 08/12/2003

FDA Requests Comments on Amending MedWatch Forms to Collect Postmarketing Adverse Event Data by Race and Ethnicity

The US Food and Drug Administration (FDA) is seeking public feedback on whether to modify its MedWatch forms to collect data on race and ethnicity in postmarketing adverse event reports, with potential implications for international reporting and financial impact on reporters.